ABSTRACT
Introduction The following section deals with infections, noninfectious diseases, drugs, and environmental exposures that exert a teratogenic or fetotoxic effect on the cardiovascular system.
Cardiovascular alterations secondary to known maternal genetic conditions (e.g., pregnancy in women with 22q11 deletion, Marfan syndrome, tuberous sclerosis, or Long Q-T syndrome) are discussed in the respective book chapters.
